These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7251134)

  • 1. Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel.
    Sigel SP; Finkelstein RA; Parker CD
    Infect Immun; 1981 May; 32(2):474-9. PubMed ID: 7251134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae.
    Sigel SP; Lanier S; Baselski VS; Parker CD
    Infect Immun; 1980 Jun; 28(3):681-7. PubMed ID: 7399688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
    Honda T; Finkelstein RA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2052-6. PubMed ID: 109838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbits.
    Tokunaga E; Cray WC; Pierce NF
    Infect Immun; 1984 May; 44(2):364-9. PubMed ID: 6715038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.
    Levine MM; Black RE; Clements ML; Lanata C; Sears S; Honda T; Young CR; Finkelstein RA
    Infect Immun; 1984 Feb; 43(2):515-22. PubMed ID: 6693169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor.
    Iwanaga M; Yamamoto K
    J Clin Microbiol; 1985 Sep; 22(3):405-8. PubMed ID: 2995438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and nucleotide sequence analysis of cholera toxin genes of the CtxA- Vibrio cholerae strain Texas Star-SR.
    Brickman TJ; Boesman-Finkelstein M; Finkelstein RA; McIntosh MA
    Infect Immun; 1990 Dec; 58(12):4142-4. PubMed ID: 2254034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Vibrio cholerae virulence genes in response to environmental signals.
    Peterson KM
    Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae.
    Baselski VS; Medina RA; Parker CD
    Infect Immun; 1979 Apr; 24(1):111-6. PubMed ID: 457267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.
    Richardson K
    Infect Immun; 1991 Aug; 59(8):2727-36. PubMed ID: 1855990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrio cholerae intestinal population dynamics in the suckling mouse model of infection.
    Angelichio MJ; Spector J; Waldor MK; Camilli A
    Infect Immun; 1999 Aug; 67(8):3733-9. PubMed ID: 10417131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
    Levine MM; Black RE; Clements ML; Cisneros L; Saah A; Nalin DR; Gill DM; Craig JP; Young CR; Ristaino P
    J Infect Dis; 1982 Mar; 145(3):296-9. PubMed ID: 7061878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.
    Pierce NF; Cray WC; Kaper JB; Mekalanos JJ
    Infect Immun; 1988 Jan; 56(1):142-8. PubMed ID: 2447017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonization of the rabbit small intestine by clinical and environmental isolates of non-O1 Vibrio cholerae and Vibrio mimicus.
    Spira WM; Fedorka-Cray PJ; Pettebone P
    Infect Immun; 1983 Sep; 41(3):1175-83. PubMed ID: 6885157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.
    Nair GB; Faruque SM; Bhuiyan NA; Kamruzzaman M; Siddique AK; Sack DA
    J Clin Microbiol; 2002 Sep; 40(9):3296-9. PubMed ID: 12202569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae.
    Finn TM; Reiser J; Germanier R; Cryz SJ
    Infect Immun; 1987 Apr; 55(4):942-6. PubMed ID: 3557620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal analysis of acid adaptation-mediated Vibrio cholerae hyperinfectivity.
    Angelichio MJ; Merrell DS; Camilli A
    Infect Immun; 2004 Apr; 72(4):2405-7. PubMed ID: 15039369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.